Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reviewing the ketamine model for schizophrenia
Joel Frohlich, John D. Van Horn
Journal of Psychopharmacology (2013) Vol. 28, Iss. 4, pp. 287-302
Open Access | Times Cited: 281

Showing 26-50 of 281 citing articles:

Multivariate patterns of EEG microstate parameters and their role in the discrimination of patients with schizophrenia from healthy controls
Máté Baradits, István Bitter, Pál Czobor
Psychiatry Research (2020) Vol. 288, pp. 112938-112938
Open Access | Times Cited: 69
A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: Results from a randomized, controlled laboratory study
Elias Dakwar, Edward V. Nunes, Carl L. Hart, et al.
Neuropharmacology (2018) Vol. 142, pp. 270-276
Open Access | Times Cited: 64
Curcumin in depressive disorders: An overview of potential mechanisms, preclinical and clinical findings
Fernanda Neutzling Kaufmann, Marta Gazal, Clarissa Ribeiro Bastos, et al.
European Journal of Pharmacology (2016) Vol. 784, pp. 192-198
Closed Access | Times Cited: 62
A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk
Valerie J. Sydnor, David R. Roalf
Schizophrenia Research (2020) Vol. 226, pp. 61-69
Open Access | Times Cited: 56
Oxidation-reduction mechanisms in psychiatric disorders: A novel target for pharmacological intervention
A.C. Rossetti, Maria Serena Paladini, Marco Andrea Riva, et al.
Pharmacology & Therapeutics (2020) Vol. 210, pp. 107520-107520
Closed Access | Times Cited: 53
Functional connectivity signatures of NMDAR dysfunction in schizophrenia—integrating findings from imaging genetics and pharmaco-fMRI
Arnim Johannes Gaebler, Nilüfer Fakour, Felix Stöhr, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Ketamine induced synaptic plasticity operates independently of long-term potentiation
Michelle K. Piazza, Ege T. Kavalali, Lisa M. Monteggia
Neuropsychopharmacology (2024) Vol. 49, Iss. 11, pp. 1758-1766
Open Access | Times Cited: 5
ITI-007 in the treatment of schizophrenia: from novel pharmacology to clinical outcomes
Robert E. Davis, Christoph U. Correll
Expert Review of Neurotherapeutics (2016) Vol. 16, Iss. 6, pp. 601-614
Open Access | Times Cited: 56
Pharmacological fMRI: Effects of subanesthetic ketamine on resting-state functional connectivity in the default mode network, salience network, dorsal attention network and executive control network
Felix Mueller, Francesco Musso, Markus K. London, et al.
NeuroImage Clinical (2018) Vol. 19, pp. 745-757
Open Access | Times Cited: 56
The profile of cognitive impairments in chronic ketamine users
Xiaoyin Ke, Yi� Ding, Ke Xu, et al.
Psychiatry Research (2018) Vol. 266, pp. 124-131
Closed Access | Times Cited: 55
Effects of Perinatal Exposure to Ketamine on the Developing Brain
Hoi Man Cheung, David T. Yew
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 52
Glutamatergic Deficits in Schizophrenia – Biomarkers and Pharmacological Interventions within the Ketamine Model
Moritz Haaf, Gregor Leicht, Stjepan Ćurić, et al.
Current Pharmaceutical Biotechnology (2018) Vol. 19, Iss. 4, pp. 293-307
Open Access | Times Cited: 46
GPCR-Based Dopamine Sensors—A Detailed Guide to Inform Sensor Choice for In Vivo Imaging
Marie A. Labouesse, Reto B. Cola, Tommaso Patriarchi
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8048-8048
Open Access | Times Cited: 42
Chronic administration of ketamine induces cognitive deterioration by restraining synaptic signaling
Yayan Luo, Yu Yang, Min-Ling Zhang, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 9, pp. 4702-4718
Closed Access | Times Cited: 41
The neurophysiology of ketamine: an integrative review
Rebecca McMillan, Suresh Muthukumaraswamy
Reviews in the Neurosciences (2020) Vol. 31, Iss. 5, pp. 457-503
Closed Access | Times Cited: 39
Ketamine disrupts naturalistic coding of working memory in primate lateral prefrontal cortex networks
Megan Roussy, Rogelio Luna, Lyndon Duong, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 11, pp. 6688-6703
Open Access | Times Cited: 36
Optogenetic perturbation of projections from thalamic nucleus reuniens to hippocampus disrupts spatial working memory retrieval more than encoding
Faiyaz Rahman, Roshan Nanu, Nathan A. Schneider, et al.
Neurobiology of Learning and Memory (2021) Vol. 179, pp. 107396-107396
Open Access | Times Cited: 32
Neuroprotective effects of alpha-pinene against behavioral deficits in ketamine-induced mice model of schizophrenia: Focusing on oxidative stress status
Akbar Hajizadeh Moghaddam, Fatemeh Malekzadeh Estalkhi, Sedigheh Khanjani Jelodar, et al.
IBRO Neuroscience Reports (2024) Vol. 16, pp. 182-189
Open Access | Times Cited: 4
Neuronal activation sequences in lateral prefrontal cortex encode visuospatial working memory during virtual navigation
Alexandra Busch, Megan Roussy, Rogelio Luna, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Esketamine in depression: putative biomarkers from clinical research
Jenessa N. Johnston, Carlos A. Zarate, Mark D. Kvarta
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 4
Effects of combined postweaning social isolation and ketamine administration on schizophrenia-like behaviour in male Sprague Dawley rats
Khanyiso Bright Shangase, Mluleki Luvuno, Musa V. Mabandla
Behavioural Brain Research (2024) Vol. 476, pp. 115214-115214
Open Access | Times Cited: 4
Repeated administration of a subanesthetic dose of ketamine results in impaired motor and cognitive behavior and differential expression of hippocampal P2X1 and P2X7 receptors in adult mice
Teresa Belem Mares-Barbosa, Ares Orlando Cuellar-Santoyo, Victor Manuel Ruiz-Rodríguez, et al.
Behavioural Brain Research (2025), pp. 115441-115441
Closed Access
Ketamine administration during adolescence impairs synaptic integration and inhibitory synaptic transmission in the adult dentate gyrus.
Odra Santander, Sebastián B. Arredondo, Francisca García-Rojas, et al.
Progress in Neurobiology (2025), pp. 102718-102718
Closed Access
The ketamine chameleon: history, pharmacology, and the contested value of experience
Danny Diep, Sara de la Salle, Julien Thibault Lévesque, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
Gastrodin Mitigates Ketamine-Induced Inhibition of F-Actin Remodeling and Cell Migration by Regulating the Rho Signaling Pathway
Ping-Cheng Shih, I‐Shiang Tzeng, Yi-Chyan Chen, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 649-649
Open Access

Scroll to top